Experimental therapy of relapsing-remitting multiple sclerosis with copolymer-1.
Johnson
K P
KP
Department of Neurology, University of Maryland, Baltimore 21201.
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control; D006801:Humans; D007557:Israel; D009103:Multiple Sclerosis / Q000188:drug therapy*; D004676:Myelin Basic Protein / Q000737:chemistry; D010455:Peptides / Q000627:therapeutic use*; D010865:Pilot Projects; D010919:Placebos; D012008:Recurrence; D016896:Treatment Outcome; D014481:United States
D004676:Myelin Basic Protein; D010455:Peptides; D010919:Placebos; C021759:(T,G)-A-L